MagicRNA Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Investors
  • 22

MagicRNA General Information

Description

Developer of RNA drugs designed for the treatment of cancer and infectious diseases. The company utilises an engineered cell-targeted lipid nanoparticle platform and an ionizable amino lipid library, enabling medical industry clients to access extrahepatic delivery solutions for nucleic acid drugs and specialised mRNA synthesis services.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 401, Building C5, Number 459 Qiaokai Road, Fenghuang Community
  • Fenghuang Street, Guangming District
  • Shenzhen, Guangdong 518107
  • China
+86 0755
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • Room 401, Building C5, Number 459 Qiaokai Road, Fenghuang Community
  • Fenghuang Street, Guangming District
  • Shenzhen, Guangdong 518107
  • China
+86 0755

MagicRNA Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MagicRNA Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC (Series B) 13-Aug-2026 Completed Generating Revenue
6. Early Stage VC 08-Dec-2025 Completed Generating Revenue
5. Early Stage VC 28-Jul-2025 Completed Generating Revenue
4. Early Stage VC 15-Jan-2024 Completed Generating Revenue
3. Early Stage VC 23-Mar-2023 Completed Generating Revenue
2. Early Stage VC 29-Dec-2022 $1.57M Completed Generating Revenue
1. Corporate 19-Apr-2022 $1.57M $1.57M Completed Generating Revenue
To view MagicRNA’s complete valuation and funding history, request access »

MagicRNA Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bayland Capital Corporate Venture Capital Minority
BOC Financial Assets Investment Growth/Expansion Minority
CDB Venture Venture Capital Minority
Hangzhou Capital Government Minority
MPC (Beijing) Venture Capital Minority
You’re viewing 5 of 22 investors. Get the full list »

MagicRNA FAQs

  • When was MagicRNA founded?

    MagicRNA was founded in 2021.

  • Where is MagicRNA headquartered?

    MagicRNA is headquartered in Shenzhen, China.

  • What industry is MagicRNA in?

    MagicRNA’s primary industry is Drug Discovery.

  • Is MagicRNA a private or public company?

    MagicRNA is a Private company.

  • What is MagicRNA’s current revenue?

    The current revenue for MagicRNA is .

  • How much funding has MagicRNA raised over time?

    MagicRNA has raised $15.5M.

  • Who are MagicRNA’s investors?

    Bayland Capital, BOC Financial Assets Investment, CDB Venture, Hangzhou Capital, and MPC (Beijing) are 5 of 22 investors who have invested in MagicRNA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process